Novel Herbal Formula YQXF Shows Promise in Treating COPD

Strategic Insights -

Researchers at the Yunnan University of Chinese Medicine have made significant progress in understanding the therapeutic potential of a novel herbal formula, YQXF, in treating chronic obstructive pulmonary disease (COPD). According to the study, YQXF not only reduces inflammation levels in lung tissue but also repairs the intestinal barrier in COPD rats. The formula's ability to regulate the pulmonary and intestinal flora by increasing the abundance of beneficial bacteria and reducing the abundance of pathogenic bacteria is a key factor in its therapeutic effects.

Key Takeaways:

  • The Yi-Qi-Xuan-Fei Formula (YQXF) is a clinically effective formula with potential to delay the progression of COPD.
  • YQXF reduces inflammatory injury and inflammatory cell infiltration in lung tissue, repairs the intestinal mucosal barrier, and enhances immune function.
  • The formula regulates the pulmonary and intestinal flora by increasing the abundance of Alloprevotella, Roseburia, Oscillibacter, and Lactobacillus, while reducing the abundance of Fusobacterium, Escherichia/Shigella, and Clostridium sensu stricto.
  • YQXF elevates the levels of short-chain fatty acids produced by the intestinal flora.
  • The study found that YQXF has anti-inflammatory and tissue damage prevention effects based on its intervention in the pulmonary and intestinal flora.
  • The findings provide valuable insights into the fundamental mechanism of YQXF and suggest targeting the intestinal flora as a potential therapeutic approach for COPD.
  • The study was conducted using rat models and has been peer-reviewed.
  • The research team included Li-Yun Song, Si-Si Han, Peng-Tao Liang, Yin-Ying Wang, Yi Ying, Li Li, Jia-Li Yuan, and Zhong-Shan Yang.

Statistics:

  • 33(3): a specific issue of the Journal of Food and Drug Analysis where the study is published.
  • 252-276: the page numbers where the study's findings are reported.
  • 650500: the zip code of Kunming, People's Republic of China, where Yunnan University of Chinese Medicine is located.
  • People's Republic of China: the country where the research was conducted.
  • Asia: the region where the research was conducted.
  • 4842: the page number where the news report is published.
  • October 20, 2025: the date when the news report was published.
  • 2025: the year when the study was conducted.

Sources:

  • Yi-Qi-Xuan-Fei Formula ameliorate chronic obstructive pulmonary disease by remodeling lung and intestinal florase in rat models. Journal of Food and Drug Analysis, 2025;33(3):252-276.
  • NewsRx. Reports from Yunnan University of Chinese Medicine Describe Recent Advances in Chronic Obstructive Pulmonary Disease (Yi-Qi-Xuan-Fei Formula ameliorate chronic obstructive pulmonary disease by remodeling lung and intestinal florase in rat models). Respiratory Therapeutics Week. October 20, 2025; p 4842.